Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SIRT2 antibody

This anti-SIRT2 antibody is a Rabbit Polyclonal antibody detecting SIRT2 in WB and ELISA. Suitable for Human.
Catalog No. ABIN1169091

Quick Overview for SIRT2 antibody (ABIN1169091)

Target

See all SIRT2 Antibodies
SIRT2 (Sirtuin 2 (SIRT2))

Reactivity

  • 75
  • 58
  • 51
  • 8
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 75
  • 11
  • 1
Rabbit

Clonality

  • 65
  • 22
Polyclonal

Conjugate

  • 50
  • 9
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This SIRT2 antibody is un-conjugated

Application

  • 56
  • 18
  • 17
  • 16
  • 15
  • 12
  • 11
  • 10
  • 3
  • 2
  • 2
  • 2
  • 1
Western Blotting (WB), ELISA
  • Specificity

    Recognizes human sirtuin 2. Detects a band of ~45 kDa by Western blot.

    Cross-Reactivity

    Human

    Sterility

    0.2 μm filtered

    Immunogen

    Recombinant human sirtuin 2.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.

    Preservative

    Without preservative

    Storage

    4 °C,-20 °C

    Storage Comment

    Short Term Storage: +4°C
    Long Term Storage: -20°C
    Stable for at least 6 months after receipt when stored at -20°C.

    Expiry Date

    6 months
  • Target

    SIRT2 (Sirtuin 2 (SIRT2))

    Alternative Name

    Sirtuin 2

    Background

    Sirtuin-2 is a NAD-dependent protein deacetylase, which deacetylates the 'Lys-40' of a-tubulin. It is involved in the control of mitotic exit in the cell cycle. Furthermore, a variety of age-associated diseases such as type 2 diabetes, obesity, osteoporosis, and Alzheimer's disease are associated with sirtuins. Selective inhibition of Sirtuin-2 achieves neuroprotection and identifies Sirtuin-2 to be a potential therapeutic avenue in Huntington's and Parkinson's disease.

    UniProt

    Q8IXJ6
You are here:
Chat with us!